|
Brief Summary
|
INTRODUCTION
Pediatric surgery has made significant
progress in recent years, with the advancement in surgical techniques and anesthesia.
However, despite these advances, managing hemodynamic changes during surgery
remains a significant challenge. Hemodynamic instability can lead to various
complications, such as ischemia, hypoxia, organ dysfunction, prolonged recovery
time, and increased hospital stays. Therefore, managing hemodynamics during
surgery is crucial to minimize the risk of adverse outcomes. Hemodynamic
instability during surgery is particularly problematic in pediatric patients,
who have a smaller circulating blood volume and are more prone to hypovolemia.
In addition, infants and children may have comorbidities that further increase
their risk of hemodynamic instability, such as congenital heart disease or
asthma.
Infraumbilical surgeries are common in
pediatric patients, and they include procedures such as hernia repair,
orchidopexy, and appendectomy. The effects of anesthesia and surgery on
hemodynamics during these procedures are of particular interest, as they can
have significant implications for patient outcomes.
While several studies have investigated the
effects of ketamine, fentanyl, and dexmedetomidine on hemodynamics during adult
surgeries, limited research has been conducted in pediatric patients undergoing
infraumbilical surgeries. Thus, the aim of this study is to compare the effects
of ketamine, fentanyl, and dexmedetomidine infusions on hemodynamics in
pediatric patients undergoing infraumbilical surgeries
Ketamine, fentanyl, and dexmedetomidine
are commonly used drugs in pediatric anesthesia. Each of these drugs has unique
properties that make them suitable for use in different clinical scenarios.
Ketamine, for example, is known for its analgesic and dissociative properties,
while fentanyl is a potent analgesic that is often used to supplement general
anesthesia. Dexmedetomidine, on the other hand, is a selective alpha-2
adrenergic agonist that produces sedation and analgesia while maintaining
cardiovascular stability.
Ketamine
is a dissociative anesthetic that has been
used in pediatric anesthesia for several decades. Ketamine produces analgesia,
amnesia, and dissociation from the surrounding environment while preserving
cardiovascular stability. Ketamine is known to increase blood pressure and
heart rate, making it particularly useful in patients with hypotension or
bradycardia.
Fentanyl
is a synthetic opioid that produces potent analgesia and sedation. Fentanyl is
often used as an adjunct to general anesthesia to improve pain control and
reduce the requirements for other anesthetic drugs. Fentanyl is known to cause
respiratory depression, but it has a minimal effect on hemodynamics, making it
an attractive option in patients with hemodynamic instability.
Dexmedetomidine
is a selective alpha-2 adrenergic agonist
that produces sedation and analgesia while maintaining cardiovascular
stability. Dexmedetomidine reduces sympathetic tone, leading to a reduction in
heart rate and blood pressure. Dexmedetomidine has been shown to reduce the
requirements for other anesthetic drugs, making it an attractive option in
patients who are at risk of hemodynamic instability
Hypothesis
Overall,
we anticipate that each drug will have a distinct effect on hemodynamics, and
that understanding these differences will be useful in guiding anesthetic
management during pediatric infraumbilical surgeries.
Fahim HM e al. (2022) [7] aimed of this study was to compare
the effect of dexmedetomidine versus ketamine when added to caudal bupivacaine
on the incidence of emergence delirium (ED), postoperative sedation, and
analgesia in pediatric patients undergoing inguinal hernia repair under
sevoflurane anesthesia. Random assignment of 87 pediatric patients who
underwent elective inguinal hernia repair under sevoflurane anaesthesia to one
of three equal groups. Group B (bupivacaine, n = 29), Group BK (bupivacaine and
ketamine, n = 29), and Group BD (bupivacaine and dexmedetomidine, n = 29) were
all comprised of 29 participants. Patients in group B received caudal injectate
of 1 ml/kg bupivacaine 0.25%, while patients in group BK received bupivacaine
0.25% mixed with ketamine 0.5 mg/kg and patients in group BD received
bupivacaine 0.25% mixed with dexmedetomidine 1 μg/kg. The most important
outcome measure was the incidence of postoperative ED. Secondary outcomes
included postoperative sedation scores and Face, Legs, Activity, Cry, and
Consolability (FLACC) pain scores, as well as time to initial postoperative
analgesic administration and total postoperative analgesic consumption. Also
evaluated was the incidence of perioperative complications. The incidence of ED
was markedly lower in groups BD and BK than in group B (P <0.05), but there
was no difference between groups BD and BK (P > 0.05). Postoperative
sedation scores were significantly higher in groups BK and BD compared to group
B at 30 minutes and 2 hours postoperatively (P <0.05 for both comparisons);
they were also significantly higher in group BD compared to group BK at (10
min–2 hours) postoperatively (P <0.05 for both comparisons). The duration of
analgesia and total postoperative paracetamol consumption were significantly
prolonged and lower in groups BD and BK, respectively, than in group B (P
<0.05); they were also significantly lower in group BD than in group BK.
There was no significant difference between groups in terms of the incidence of
perioperative complications. After sevoflurane anaesthesia, both
dexmedetomidine (1 g/kg) and ketamine (0.5 mg/kg) added to pediatric caudal block
were efficacious in controlling pediatric ED. Compared to ketamine, caudal
dexmedetomidine patients had a longer time to first postoperative analgesia and
lesspostoperative analgesic consumption, but longer postoperative sedation,
with no significant difference in the incidence of perioperative adverse events
between the two drugs.
Godbole R et al. (2020) [8] This study aimed to clinically
evaluate and compare the efficacy of caudal epidural bupivacaine in prolonging
the postoperative analgesia, with adjuvants like fentanyl or dexmedetomidine
among children of Indian genotype. A prospective, randomized, double-blind
comparison study. The study cohort of 68 Indian phenotype patients was selected
at random from a random number table and divided into two groups of 34 patients
each. Group A received 0.75 mL/kg of 0.25% bupivacaine plus 1 mcg/kg of
fentanyl, while group B received 0.75 mL/kg of 0.25% bupivacaine plus 1 mcg/kg
of dexmedetomidine. For both groups, the time from caudal injection to the
first administration of rescue analgesia will be recorded as the Global
Assessment of Anaesthesia. Results Either fentanyl or dexmedetomidine as
adjuvants in caudal block provided excellent postoperative analgesia, with
dexmedetomidine sedation lasting substantially longer (18.0 hours) than
fentanyl (13.1 hours). In both groups, we observed adequate hemodynamic
stability. Conclusion Addition of dexmedetomidine over fentanyl to bupivacaine
for caudal epidural analgesia in children has multiple benefits, including
improved intraoperative and postoperative hemodynamic control, significantly
longer duration of postoperative analgesia, less bleeding during surgery, and
good surgical satisfaction. As the children are pain-free, calm, silent,
sedated, yet arousable, the parents’ contentment is rewarding. In the Indian
population, the caudal epidural dose of 0.25% bupivacaine 0.75 mL/kg with
adjuvants such as dexmedetomidine or fentanyl is efficacious for postoperative
analgesia in lower abdominal surgeries without adverse effects.
Park SJ et al. (2017) [9] aimed of study was to compare the
efficacy and safety of dexmedetomidine with that of fentanyl as an adjuvant to
epidural ropivacaine in pediatric Orthopedic surgery. This study enlisted sixty
(3–12-year-old) children scheduled for lower extremity orthopedic surgery and
lumbar epidural patient-controlled analgesia (PCA). Children received either
dexmedetomidine (1 μg/kg) or fentanyl (1 μg/kg) via epidural catheter along
with 0.2% ropivacaine (0.2 mL/kg) 30 minutes prior to the conclusion of
surgery. The children weremonitored postoperatively for ropivacaine consumption
via epidural PCA, postoperative pain intensity, the requirement for rescue
analgesics, emergence agitation, and other adverse effects. In the first six
hours after surgery, the mean dose of bolus epidural ropivacaine was
significantly lower in the dexmedetomidine group than in the fentanyl group
(0.029±0.030 mg/kg/h vs. 0.053±0.039 mg/kg/h, p=0.012). The median pain score
at six hours postoperatively was lower in the dexmedetomidine group than in the
fentanyl group [0 (0–1.0) vs. 1.0 (0–3.0), p=0.039]. Throughout the duration of
the investigation, the need for rescue analgesia did not differ between groups.
In the early postoperative period, the use of dexmedetomidine as an epidural
adjuvant had a substantially greater analgesic and local anesthetic-sparing
effect than fentanyl in children undergoing major Orthopedic lower extremity
surgery.
Elfawal SM et al. (2016) [10] Levobupivacaine is an effective
local anesthetic agent with less systemic toxicity than racemic bupivacaine,
but it has short postoperative analgesic duration. Dexmedetomidine and fentanyl
are promising adjuncts for postoperative caudal analgesia that is both
effective and long-lasting. This study compared the postoperative analgesia and
sedation effects of caudal levobupivacaine plus dexmedetomidine and
levobupivacaine plus fentanyl in minors undergoing lower limb orthopedic surgery.
Ninety children aged 1 to 7 years, American Society of Anesthesiologists I-II,
who underwent orthopedic lower limb surgery under general anaesthesia were
administered caudal block for postoperative analgesia. Random assignment of the
students to three groups: Group L (control) received 0.75 ml/kg levobupivacaine
0.25% diluted in saline. Group LD received 0.75 ml/kg levobupivacaine 0.25%
with dexmedetomidine 1 µg/kg. Following drug administration, hemodynamic
variables, total anaesthesia time, sedation score, Face, Legs, Activity, Cry,
Consolability score, analgesia duration, and adverse effects were recorded.
Both the baseline and intraoperative profiles of hemodynamic were comparable
across all groups. In Group LD, the mean duration of analgesia and the mean
sedation score were substantially greater than in the other two groups.
Dexmedetomidine may be a superior additive to levobupivacaine than fentanyl for
caudal postoperative analgesia and arousable sedation in children, with
comparable hemodynamic and adverse effect profiles.
Bharti N et al. (2014) [11] This randomized double-blind study
was conducted to evaluate the analgesic efficacy and safety of addition of
three different doses of dexmedetomidine in caudal ropivacaine compared with
plain ropivacaine for postoperative analgesia in pediatric day care patients.
Included were eighty 1–8-year-old American Society of Anesthesiologists grade
I–II minors undergoing lower abdominal and perineal surgery. Children were
divided into four groups at random. Group 1 received 0.2% ropivacaine 0.75
ml.kg-1 without dexmedetomidine, while groups 2, 3, and 4 received
dexmedetomidine in addition to 0.2% ropivacaine 0.75 ml.kg-1.5 µg.kg-1. With
sevoflurane and 50% N2O in oxygen, anaesthesia was induced and maintained.
Postoperative pain, nausea and vomiting, agitation, sedation, and adverse
effects were monitored in children. Oral paracetamol was administered as rescue
analgesia. All dexmedetomidine groups significantly prolonged postoperative
analgesia compared to the ropivacaine group (P <0.001). In the first six
postoperative hours, all patients in the ropivacaine group required rescue
analgesia, whereas none in the other three groups did. No patient experienced
delayed anaesthetic emergence. Four patients in the ropivacaine-alone group
developed agitation, but none in the dexmedetomidine-alone group did. Patients
receiving 1.5 µg/kg dexmedetomidine were more sedated than those in the other
groups (P <0.01), but it did not impede their discharge. Conclusions: It
appears that all three doses of caudal dexmedetomidine are efficacious for
preventing postoperative pain in pediatric patients receiving day care. These
doses of caudal dexmedetomidine appear to be safe for day surgery.
AIMS AND OBJECTIVES
AIM
â–ª
To compare the efficacy of ketamine, fentanyl
and dexmedetomidine infusions on hemodynamic control and overall outcome in
pediatric infraumbilical surgeries.
PRIMARY
OBJECTIVE
·
To compare the effect of ketamine, fentanyl and
dexmedetomidine infusions on hemodynamic control (PR, SBP, DBP, MAP, SpO2) in
pediatric infraumbilical surgeries.
SECONDARY OBJECTIVES
- To compare the time of emergence (TE)
- To compare the sedation score at the emergence
(RSS)
- To compare the pain score(CHEOPS)
·
To compare of time of
first rescue analgesic (TR)
- To compare the total number and doses of rescue
analgesics
- To study the complications
- PONV
- Respiratory Depression
- Arrythmia
MATERIAL AND METHODS
Study Setting:
·
The study will be conducted by Department of
Anaesthesiology, King George’s Medical University, Lucknow in collaboration
with Departments of Pediatric Surgery, KGMU, Lucknow after getting clearance
from the ethical committee, Research Cell, KGMU, Lucknow.
Study Design:
·
Single Centre, Prospective, Randomized Controlled
Study
Study Duration:
·
One and a half year
Sample
Size:
N= 24 in each group (72)
The sample size formulae used are as
follows: (Bernard, 5th edition) [12]
n=
n= (20.512+9.22)/1(1.64+0.84)2
11.42
n= (420.66+84.64)/1(6.15)
129.96
n= (505.3001) (6.15) = 3122.854 = 24.02 (in each group)
≈24
129.96 129.96
n= Sample size
σ1 = Standard Deviation
cases [=20.51] *
σ2 = Standard Deviation
control [=9.2] *
∆ = Difference of means [=11.4]
κ= Ratio [=1]
Z1-α/2= Two-sided Z value
[=1.64]
Z1-β= Power [=0.84]
*Assumed
|
Confidence Interval (2-sided)
|
90%
|
|
|
Power
|
80%
|
|
|
|
|
Mean Heart rate at 9 hr
(R Godbole et al., 2020) [13]
|
Group-A
|
|
Group-B
|
|
Difference*
|
|
Mean
|
111.7
|
|
100.3
|
|
11.4
|
|
Standard deviation*
|
20.51
|
|
9.2
|
|
|
Variance
|
420.66
|
|
84.64
|
|
|
|
|
Sample size
|
72
|
|
|
|
|
|
|
Total Sample size 72 (24 in
each group)
|
Statistical Analysis:
Data will be entered in Microsoft Excel and analyzed using
statistical software SPSS version 15 (Chicago, IL, USA). Statistical analysis
will be performed using SPSS software (SPSS Inc., Chicago, IL, USA) for Windows
program (15.0 version). The continuous variables will be evaluated by mean
(standard deviation) or range value when required. The dichotomous variables will
be presented in number/frequency and will be analyzed using Chi-square or
Fisher Extract test. For comparison of the means between the two groups,
analysis by Student t-test, Mann-Whitney U test, and Spearman correlation with
95% confidence interval will be used. A p-value of < 0.05 will be regarded
as significant
Inclusion Criteria:
·
Patients of either sex and age
group of 1-8 years
·
American Society of
Anesthesiologists (ASA) I–II
·
Elective Pediatric
Infraumbilical Surgeries
Exclusion Criteria:
·
Patient’s/ Guardian’s
Refusal
·
Congenital Herat disease
·
Coagulation Disorders
·
Allergy to study drugs
·
Patients with mental developmental delay
·
Severe Systemic Diseases
METHODOLOGY
After Institutional Ethics Committee
approval &Informed Patient’s/Guardian’s Consent, total 72 patients (24
in each group), ASA I & II, of either sex and age group of 1 to 8years
undergoing elective pediatric infraumbilical surgery will be included in the
study.
As per institutional protocol, all
patients will be examined on the night before surgery, and instruction
regrading NPO, premedication will be given.
Total 72, patients will be randomly divided into three groups (24 in
each group) using a computer-generated random table. Group Fwill be
receiving intravenous fentanyl 2 mcg/kg bolus for induction and 1 mcg/kg/hr for
maintenancewhereas Group K will be receiving intravenous ketamine 1.5
mg/kg for 10 minutes before induction and 0.5 mg/kg/hr for maintenance[18]
and Group D will be receiving intravenous dexmedetomidine 1mcg/kg for 10
minutes before induction and 0.5 mcg/kg/hr for maintenance.[14, 15,16,17]
|
GROUP
|
DRUG
|
|
Group
F
(Fentanyl)
|
Induction: 2mcg/kg (bolus)
Maintenance: 1mcg/kg/hr (infusion)
|
|
Group
K
(Ketamine)
|
Induction: 1.5mg/kg (infusion)
Maintenance: 1mg/kg/hr (infusion)
|
|
Group
D
(Dexmedetomidine)
|
Induction: 1mcg/kg (infusion)
Maintenance: 0.5mcg/kg/hr (infusion)
|
All
children will be premedicated with midazolam 0.5mg/kg19 and atropine
0.03mg/kg19 orally 30 minutes before induction, and standard ASA
monitor will be attached and intravenous access will be secured under
inhalational anesthesia. Anaesthesia will be induced in Group Fwill be
receiving fentanyl intravenous 2 mcg/kg bolus for induction whereas Group K
will be receiving ketamine intravenous 1.5mg/kg for 10 minutes before induction
and Group D will be receiving dexmedetomidine 1mcg/kg for 10 minutes before
induction followed by intravenous propofol 2 -2.5mg/kg and myorelaxation will
be achieved by intravenous atracurium 0.5mg/kg , and after 3 min of controlled
ventilation, end tidal carbon dioxide will be maintained between 30-35 mm Hg,
tracheal will be secured with endotracheal tube.Anaesthesia will be maintained
with 60% Air and 40% in oxygen and 1.5-2.0% sevoflurane with desired MAC up to
0.8 to 1.0, along with continuous infusion of, fentanyl @ 1mcg/kg/hr
intravenously, ketamine @ 0.5mg/kg/hr intravenously and dexmedetomidine @
0.5mcg/kg in Group F, K & D respectively and atracurium at dose of 0.3-0.4mg/kg/hr
intravenously.Myorelaxation will be monitored using train of four (TOF)
monitoring. At
the end of the surgery, all
infusion will be stopped and neuromuscular blockade will be reversed
with neostigmine 0.05 mg/kg and glycopyrrolate 0.001 mg/kg, time of emergence(TE)will
be noted as the time duration from stoppage of infusion to extubation. Patients
will be extubated when they will able to obey simple commands (RSS>3).
During intra-operative period hemodynamics
(PR, SBP,
DBP, MAP, SpO2) will be recoded at T0 (before induction), T1 (just after
intubation), T3 (5 minutes after T0), T4 (15 minutes after T0), and later on at
the interval 15 minutes till end of surgery.
After discharge from the recovery room,
the children will be transferred to the surgical ward. Sedation will be
assessed after the extubation using Ramsay SedationScore and pain will
be assessed at the time of extubation, 1 hour, 2 hour, 6 hour, 12 hour and 24
hour after extubation,by using the Children’s Hospital of Eastern Ontario
Pain Scale (CHEOPS), a multifactorial pain scale graded from 4 to 13, based
on scores for cry, facial expression, verbal expression and movement in infants
and children.20 If the CHEOPS score exceeded 7, additional
intravenous boluses of rescue analgesics (1. Paracetamol (10 mg/kg), 2. Ketorolac
(0.5mg/kg), and 3. Tramadol (1mg/kg)will be given. The number of CHEOPS
exceeding 7 and the supplemental bolus dose of paracetamol will be recorded for
24 h. Potential side effects of fentanyl, ketamine and dexmedetomidine will also
be recorded, including nausea, vomiting and psychomimetic side effects such as
nightmares or hallucinations. At the end of the 24 h, the parents’ satisfaction
will be assessed using Parents Satisfaction Score.
HEMODYNAMICS
|
TIME/PARAMETER
|
PR
|
SBP
|
DBP
|
MAP
|
SPO2
|
|
T0
|
|
|
|
|
|
|
T1
|
|
|
|
|
|
|
T2
|
|
|
|
|
|
|
T3
|
|
|
|
|
|
|
T4
|
|
|
|
|
|
|
TN
|
|
|
|
|
|
[T0 (before induction), T1 (just after intubation), T3 (5
minutes after T0), T4 (15 minutes after T0), and later on at the interval 15
minutes till end of surgery.]
PARENTS
SATISFACTION SCORE
|
Grade
|
Level of Satisfaction
|
|
I
|
Excellent
|
|
II
|
Very good
|
|
III
|
Satisfactory
|
|
IV
|
Poor
|
CHILDREN’S
HOSPITAL OF EASTERN ONTARIO PAIN SCALE (CHEOPS)
COMPLICATIONS
& MANAGEMENT
|
Pain
|
Rescue Analgesics
Paracetamol
10-15 mg/kg IV
|
|
Ketorolac
0.5 mg/kg IM/IV
|
|
Tramadol
1-2 mg/kg IV
|
|
Bradycardia
|
Atropine
0.05mg/Kg
|
|
PONV
|
Ondansetron
0.15 mg/kg IV
|
|
Respiratory depression
|
Oxygenation
|
|
Naloxone
0.4 mg IV repeated to max. dose of 8 mg
|
ASSESSMENT
1. HEMODYNAMICS(PR, SBP, DBP, MAP,
SpO2)
2. TIME OF EMERGENCE (TE)
3. SEDATION SCORE AT EMERGENCE (RSS)
4. PAIN
SCORE (CHEOPS)
5. TIME
OF FIRST RESUCE ANALGESIC (TR)
6. RESCUE
ANALGESIC
a. Paracetamol
b. Ketorolac
7. COMPLICATIONS
- Pain
- PONV
- Respiratory Depression
- Arrythmia
- Ileus
REFERENCES
1.
Dahl JB, Kehlet H. Preventive analgesia.
CurrOpinAnaesthesiol 2011;24(3):331–338
2.
Srouji R, Ratnapalan S, Schneeweiss S. Pain in
children: assessment and nonpharmacological management. Int J Pediatr 2010;
2010:474838
3.
Caudal Epidural Block A, Review. Anaesthesia
Today. December 19, 2010
4.
Polomano RC, Fillman M, Giordano NA, Vallerand
AH, Nicely KL, Jungquist CR. Multimodal analgesia for acute postoperative and
trauma –related pain. Am J Nurs 2017;117(3, Suppl 1): S12–S26
5.
Miller RD. Miller’s Anaesthesia. 8th ed.
Philadelphia: Elsevier Saunders; 1600
6.
Lönnqvist PA. Adjuncts to caudal block in
children–Quo vadis? Br J Anaesth 2005;95(4):431–433
7. Fahim HM, Menshawi MA.
Effect of caudal dexmedetomidine versus ketamine in prevention of emergence
delirium in pediatric patients undergoing congenital inguinal hernia repair
under sevoflurane anesthesia. Ain-Shams Journal of Anesthesiology. 2022 May 12;14(1):45.
8. Godbole R, Gill J,
Bhattacharya B, Shrotriya S, Shrivastava S, Bandari A. A Randomized Controlled
Double-Blind Comparative Study between Bupivacaine 0.25% Plus Fentanyl and
Bupivacaine 0.25% Plus Dexmedetomidine for Caudal Epidural Postoperative
Analgesia in Pediatric Lower Abdominal and Urogenital Surgeries in Indian
Genotype. International Journal of Recent Surgical and Medical Sciences. 2020
Jun;6(01):30-7.
9.
Park SJ, Shin S, Kim SH, Kim HW, Kim SH, Do HY,
Choi YS. Comparison of dexmedetomidine and fentanyl as an adjuvant to
ropivacaine for postoperative epidural analgesia in pediatric orthopedic
surgery. Yonsei medical journal. 2017 May 1;58(3):650-7.
10. Elfawal SM, Abdelaal WA,
Hosny MR. A comparative study of dexmedetomidine and fentanyl as adjuvants to
levobupivacaine for caudal analgesia in children undergoing lower limb
orthopedic surgery. Saudi journal of anaesthesia. 2016 Oct;10(4):423.
11. Bharti N, Praveen R,
Bala I. A dose–response study of caudal dexmedetomidine with ropivacaine in
pediatric day care patients undergoing lower abdominal and perineal surgeries:
a randomized controlled trial. Pediatric Anesthesia. 2014 Nov;24(11):1158-63.
12. Bernard Rosner.
Fundamentals of Biostatistics (5th edition). (Based on equation 8.27).
13. Godbole R, Gill J,
Bhattacharya B, Shrotriya S, Shrivastava S, Bandari A. A Randomized Controlled
Double-Blind Comparative Study between Bupivacaine 0.25% Plus Fentanyl and
Bupivacaine 0.25% Plus Dexmedetomidine for Caudal Epidural Postoperative
Analgesia in Pediatric Lower Abdominal and Urogenital Surgeries in Indian
Genotype. International Journal of Recent Surgical and Medical Sciences. 2020
Jun;6(01):30-7.
14. Lin R, Ansermino JM. Dexmedetomidine in
paediatric anaesthesia. BJA Educ. 2020 Oct;20(10):348-353. doi:
10.1016/j.bjae.2020.05.004. Epub 2020 Jul 22. PMID: 33456916; PMCID:
PMC7808041.
15. Bong CL, Tan J, Lim S, Low Y, Sim SW, Rajadurai
VS, Khoo PC, Allen J, Meaney M, Koh WP. Randomised controlled trial of
dexmedetomidine sedation vs general anaesthesia for inguinal hernia surgery on
perioperative outcomes in infants. Br J Anaesth. 2019 May;122(5):662-670. doi:
10.1016/j.bja.2018.12.027. Epub 2019 Mar 7. PMID: 30916007.
16. Vaughns JD, Martin C, Nelson J, Nadler E,
Quezado ZM. Dexmedetomidine as an adjuvant for perioperative pain management in
adolescents undergoing bariatric surgery: An observational cohort study. J
Pediatr Surg. 2017 Nov;52(11):1787-1790. doi: 10.1016/j.jpedsurg.2017.04.007.
Epub 2017 Apr 19. PMID: 28465076.
17. Tobias JD, Gupta P, Naguib A, Yates AR.
Dexmedetomidine: applications for the pediatric patient with congenital heart
disease. PediatrCardiol. 2011 Dec;32(8):1075-87. doi:
10.1007/s00246-011-0092-8. Epub 2011 Sep 10. PMID: 21909772.
18. Bazin V, Bollot J, Asehnoune K, Roquilly A,
Guillaud C, De Windt A, Nguyen JM, Lejus C. Effects of perioperative
intravenous low dose of ketamine on postoperative analgesia in children. Eur J
Anaesthesiol. 2010 Jan;27(1):47-52. doi: 10.1097/EJA.0b013e32832dbd2f. PMID:
19535988.
19. Feld LH, Negus JB, White PF. Oral midazolam
preanesthetic medication in pediatric outpatients. Anesthesiology. 1990
Nov;73(5):831-4. doi: 10.1097/00000542-199011000-00006. PMID: 2240672.
20. McGrath
PJ, Johnson G, Goodman JT, et al. CHEOPS: a behavioural scale for rating
postoperative pain in children. Adv Pain Res Ther 1985; 9:395– 402
|